Cg Oncology Inc.. (CGON) NASDAQ

$33.54 (1.80) (-5.09%)

Market Cap: $2.35B

As of 04/22/24 04:00 PM EDT. Market closed.

(CGON)

Cg Oncology Inc.. (CGON)
NASDAQ

$33.54
(1.80) (-5.09%)

Market Cap: $2.35B

As of 04/22/24 04:00 PM EDT. Market closed.

Add to Portfolio
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
.
PRICE CHART FOR CG ONCOLOGY INC.
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$36.33
Previous Close
$35.34
Days Range
$34.56 - $36.40
52 week range
$28.55 - $50.23
Volume
278,123
Avg. Volume (30 days)
362,705
Market Cap
$2.35B
Dividend Yield
-
P/E
-
Shares Outstanding
66,636,252
Open
$36.33
Previous Close
$35.34
Days Range
$34.56 - $36.40
52 week range
$28.55 - $50.23
Volume
278,123
Avg. Volume (30 days)
362,705
Market Cap
$2.35B
Dividend Yield
-
P/E
-
Shares Outstanding
66,636,252
FINANCIAL STATEMENTS FOR CG ONCOLOGY INC.
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CG ONCOLOGY INC.
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Decheng Capital Global Life Sciences Fund IV, L.P.10% OwnerJan 29, 2024 Buy$19.00400,0007,600,0004,958,810Apr 09, 2024, 07:08 PM
Kasturi VijayChief Medical OfficerJan 29, 2024 Buy$19.001,31524,9851,315Jan 31, 2024, 04:30 PM
Roche Corleen M.CFO & SecretaryJan 29, 2024 Buy$19.002,00038,0002,000Jan 31, 2024, 04:30 PM
Song Hong FangDirectorJan 29, 2024 Buy$19.00263,1574,999,983613,928Jan 31, 2024, 04:30 PM
Decheng Capital Global Life Sciences Fund IV, L.P.10% OwnerJan 29, 2024 Buy$19.00400,0007,600,000400,000Jan 31, 2024, 04:17 PM
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Decheng Capital Global Life Sciences Fund IV, L.P.10% Owner01/29/20247,600,000
Kasturi VijayChief Medical Officer01/29/202424,985
Roche Corleen M.CFO & Secretary01/29/202438,000
Song Hong FangDirector01/29/20244,999,983
Decheng Capital Global Life Sciences Fund IV, L.P.10% Owner01/29/20247,600,000
CHANGE IN SHARES OUTSTANDING FOR CG ONCOLOGY INC.
STOCK BUYBACKS FOR CG ONCOLOGY INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
12/31/2022
35.94%
4Q

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2022
35.94%
4Q
BUYBACK ANNOUNCEMENT(S) FOR CG ONCOLOGY INC.
LOADING...